A股午評:滬指跌1.42% 部分中字頭概念續升 旅遊股集體大跌
A股主要指數低開低走,截至午間收盤,滬指跌1.42%報3013.84點,深證成指跌1.56%,創業板指跌1.16%。超5000股下跌,兩市半日成交6173億元,北向資金淨賣出約44.8億元。盤面上,業績高增長股受追捧,贛能股份、榮泰健康一字升停,贛能股份預吿2024年一季度淨利潤增長3286%-3790%,榮泰健康預吿一季度淨利潤增長58%-72%;部分中字頭概念升勢延續,中鐵裝配升超12%,中公高科升停;旅遊股集體大跌,張家界、大連聖亞等多股跌停;服裝家紡板塊走低,太平鳥、安奈兒等多股跌停;殼資源板塊延續跌勢,萬方發展、寧波中百等多股跌停;教育、零售、環保等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.